Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Veena Mathew,1 Annabel K Wang1,2 1Department of Neurology, UCI ALS and Neuromuscular Center, University of California, Irvine, Orange, CA, USA; 2Neurology Section, Tibor Rubin VA Medical Center, Long Beach, CA, USA Abstract: Hereditary transthyretin amyloidosis is a fatal autosomal dominant disord...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-05-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/inotersen-new-promise-for-the-treatment-of-hereditary-transthyretin-am-peer-reviewed-article-DDDT |